<SEC-DOCUMENT>0001104659-25-121424.txt : 20251216
<SEC-HEADER>0001104659-25-121424.hdr.sgml : 20251216
<ACCEPTANCE-DATETIME>20251216092653
ACCESSION NUMBER:		0001104659-25-121424
CONFORMED SUBMISSION TYPE:	6-K
PUBLIC DOCUMENT COUNT:		2
CONFORMED PERIOD OF REPORT:	20251216
FILED AS OF DATE:		20251216
DATE AS OF CHANGE:		20251216

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			Grifols SA
		CENTRAL INDEX KEY:			0001438569
		STANDARD INDUSTRIAL CLASSIFICATION:	PHARMACEUTICAL PREPARATIONS [2834]
		ORGANIZATION NAME:           	03 Life Sciences
		EIN:				000000000

	FILING VALUES:
		FORM TYPE:		6-K
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-35193
		FILM NUMBER:		251573544

	BUSINESS ADDRESS:	
		STREET 1:		1585 BROADWAY
		STREET 2:		SUITE 2376
		CITY:			NEW YORK
		STATE:			NY
		ZIP:			10036
		BUSINESS PHONE:		212-969-3335

	MAIL ADDRESS:	
		STREET 1:		1585 BROADWAY
		STREET 2:		SUITE 2376
		CITY:			NEW YORK
		STATE:			NY
		ZIP:			10036
</SEC-HEADER>
<DOCUMENT>
<TYPE>6-K
<SEQUENCE>1
<FILENAME>tm2533540d1_6k.htm
<DESCRIPTION>FORM 6-K
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<!-- Field: Rule-Page --><DIV STYLE="margin-top: 0; margin-bottom: 0; width: 100%"><DIV STYLE="font-size: 1pt; border-top: Black 2pt solid; border-bottom: Black 1pt solid">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 14pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>UNITED STATES<BR>
SECURITIES AND EXCHANGE COMMISSION</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>Washington, D.C. 20549</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 14pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>Form&nbsp;6-K</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO
RULE 13a-16 OR 15d-16<BR>
 UNDER THE SECURITIES EXCHANGE ACT OF 1934</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>For the month of December&nbsp;2025</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>Commission File No.&nbsp;001-35193</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 18pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>Grifols, S.A.</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">(Translation of registrant&rsquo;s name into English)</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>Avinguda de la Generalitat, 152-158</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>Parc de Negocis Can Sant Joan</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>Sant Cugat del Valles 08174</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>Barcelona, Spain</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">(Address of registrant&rsquo;s principal executive
office)</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Indicate by check mark whether the registrant files or will file annual
reports under cover Form&nbsp;20-F or Form&nbsp;40-F.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">Form&nbsp;20-F&#8239;<FONT STYLE="font-family: Wingdings">&#120;</FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;Form&nbsp;40-F&#8239;<FONT STYLE="font-family: Wingdings">&#168;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left">&nbsp;</P>

<!-- Field: Rule-Page --><DIV STYLE="margin-top: 0; margin-bottom: 0; width: 100%"><DIV STYLE="font-size: 1pt; border-top: Black 1pt solid; border-bottom: Black 2pt solid">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin: 0pt"></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt"></P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>Grifols, S.A.</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">TABLE OF CONTENTS</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: bottom">
    <TD COLSPAN="2" STYLE="border-bottom: Black 1pt solid"><FONT STYLE="font-size: 10pt"><B>Item</B></FONT></TD>
    <TD STYLE="text-align: center">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: center"><FONT STYLE="font-size: 10pt"><B>Sequential&nbsp;Page&nbsp;Number</B></FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD COLSPAN="2">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: center; width: 0.75in"><A HREF="#a_001"><FONT STYLE="font-size: 10pt">1.</FONT></A></TD>
    <TD STYLE="text-align: left"><A HREF="#a_001">Other Relevant Information, dated December 16, 2025</A></TD>
    <TD STYLE="width: 0.2in">&nbsp;</TD>
    <TD STYLE="text-align: right; width: 1.5in"><A HREF="#a_001"><FONT STYLE="font-size: 10pt">3</FONT></A></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"></P>

<!-- Field: Page; Sequence: 2; Options: NewSection; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->2<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt"></P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="vertical-align: top; text-align: left">
  <TD STYLE="width: 70%"><FONT STYLE="font-size: 10pt"><IMG SRC="tm2533540d1_6kimg001.jpg" ALT="" STYLE="height: 54px; width: 250px"></FONT></TD>
  <TD STYLE="width: 30%"><FONT STYLE="font-size: 10pt"><B><A NAME="a_001"></A>Grifols, S.A.<BR>
  <BR>
  </B>Avinguda de la Generalitat 152-158 <BR>
08174 Sant Cugat del Vall&egrave;s <BR>
Barcelona - SPAIN<BR>
  <BR>
  Tel. [34] 935 710 500<BR>
  Fax [34] 935 710 267<BR>
  <BR>
  <U>www.grifols.com</U></FONT></TD></TR>
</TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Pursuant to the provisions of Article 227 of Law
6/2023 of March 17, on Securities Markets and Investment Services, Grifols, S.A. (&ldquo;<B>Grifols</B>&rdquo; or the &ldquo;<B>Company&rdquo;</B>)
hereby informs about the following</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><B>OTHER RELEVANT INFORMATION</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 1pt 0pt 0; text-align: justify">Grifols informs that on December 11, 2025,
the European Medicines Agency (EMA) has issued the Certificate of Compliance with Community legislation for the plasma supplied by Grifols
Egypt for Plasma Derivatives (GEPD), the joint venture established in 2020 jointly between Grifols and Egypt&rsquo;s National Service Projects
Organization.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">This certification has been granted after the
quality inspection to the plasma centers owned by GEPD and after the review by the EMA that all procedures, selection of donors, plasma
obtention methods, quality controls, and storage (among others) comply with the quality and security standards required by European legislation.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 1pt 0pt 0; text-align: justify">This certification will allow not only
to manufacture plasma products by GEPD but also to commercialize them throughout Europe and in all countries that follow EMA legislation.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The achievement of this certification from the
EMA for the Egyptian plasma is a huge milestone for the Company and Grifols has been the first plasma company in accomplishing this significant
step.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">This recognition positions Egypt as the first
country in Africa and the Middle East to operate a fully integrated plasma collection and processing system that meets the strictest international
standards.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="vertical-align: top; text-align: left">
  <TD STYLE="width: 50%">In Barcelona, on 16 December 2025</TD>
  <TD STYLE="width: 50%">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top; text-align: left">
  <TD>&nbsp;</TD>
  <TD>&nbsp;</TD></TR>
<TR STYLE="vertical-align: top; text-align: left">
  <TD STYLE="border-bottom: Black 1pt solid">&nbsp;</TD>
  <TD>&nbsp;</TD></TR>
<TR STYLE="vertical-align: top; text-align: left">
  <TD>N&uacute;ria Mart&iacute;n Barn&eacute;s</TD>
  <TD>&nbsp;</TD></TR>
<TR STYLE="vertical-align: top; text-align: left">
  <TD>Secretary to the Board of Directors</TD>
  <TD>&nbsp;</TD></TR>
</TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 3; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->3<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt"></P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B><U>SIGNATURES</U></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">Pursuant to the requirements of the Securities
Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereto duly authorized.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD COLSPAN="3"><FONT STYLE="font-size: 10pt">Grifols,&nbsp;S.A.</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD COLSPAN="2">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD><FONT STYLE="font-size: 10pt">By:</FONT></TD>
    <TD COLSPAN="2" STYLE="border-bottom: Black 1pt solid"><FONT STYLE="font-size: 10pt">/s/ David I. Bell</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 50%">&nbsp;</TD>
    <TD STYLE="width: 3%">&nbsp;</TD>
    <TD STYLE="width: 5%"><FONT STYLE="font-size: 10pt">Name:</FONT></TD>
    <TD STYLE="width: 42%"><FONT STYLE="font-size: 10pt">David I. Bell</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD><FONT STYLE="font-size: 10pt">Title:</FONT></TD>
    <TD><FONT STYLE="font-size: 10pt">Authorized Signatory</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Date:&nbsp; December 16, 2025</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 4; Options: Last -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin: 0pt"></P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>2
<FILENAME>tm2533540d1_6kimg001.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 tm2533540d1_6kimg001.jpg
M_]C_X  02D9)1@ ! 0   0 !  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0D)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1"  V /H# 2(  A$! Q$!_\0
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MO'_VHM>S^-_^1$U__L'S_P#H!HQ$4JUDNPZ;;IW9\X?\+7\<?]!^7_OS%_\
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MU9_]@]/_ $-ZPPL7"ORLTK-.G=%C]G__ )&W5/\ KQ_]J+7L_C?_ )$37_\
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ML4AG/Z ?\"I^H_&WP?9VK26L]S?38^6**!ER?<L !7@OB[Q9J'C+7'U*^P@
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1F/)_E6S116+;;NS1*VQ__]D!

end
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
